Literature DB >> 10473512

Interleukin 4 in systemic sclerosis: not just an increase.

S P Atamas1, B White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10473512      PMCID： PMC95749          DOI： 10.1128/CDLI.6.5.658-659.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  29 in total

1.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4.

Authors:  A E Postlethwaite; M A Holness; H Katai; R Raghow
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122.

Authors:  A E Postlethwaite; J M Seyer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation.

Authors:  J G Monroe; S Haldar; M B Prystowsky; P Lammie
Journal:  Clin Immunol Immunopathol       Date:  1988-11

4.  Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines.

Authors:  P Rathanaswami; M Hachicha; M Sadick; T J Schall; S R McColl
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

5.  Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2.

Authors:  R V Sorg; J Enczmann; U R Sorg; E M Schneider; P Wernet
Journal:  Exp Hematol       Date:  1993-04       Impact factor: 3.084

6.  Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents.

Authors:  C Fertin; J F Nicolas; P Gillery; B Kalis; J Banchereau; F X Maquart
Journal:  Cell Mol Biol       Date:  1991       Impact factor: 1.770

7.  Glycosylation variants of murine interleukin-4: evidence for different functional properties.

Authors:  G Thor; A A Brian
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Detection and analysis of an alternatively spliced isoform of interleukin-6 mRNA in peripheral blood mononuclear cells.

Authors:  D P Kestler; S Agarwal; J Cobb; K M Goldstein; R E Hall
Journal:  Blood       Date:  1995-12-15       Impact factor: 22.113

9.  Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4.

Authors:  T H Piela-Smith; G Broketa; A Hand; J H Korn
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

10.  Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma.

Authors:  B W Needleman; F M Wigley; R W Stair
Journal:  Arthritis Rheum       Date:  1992-01
View more
  8 in total

1.  A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.

Authors:  Arnold E Postlethwaite; Weng Kee Wong; Philip Clements; Soumya Chatterjee; Barri J Fessler; Andrew H Kang; Joseph Korn; Maureen Mayes; Peter A Merkel; Jerry A Molitor; Larry Moreland; Naomi Rothfield; Robert W Simms; Edwin A Smith; Robert Spiera; Virginia Steen; Kenneth Warrington; Barbara White; Frederick Wigley; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2008-06

Review 2.  Regulation of inflammation by interleukin-4: a review of "alternatives".

Authors:  Irina G Luzina; Achsah D Keegan; Nicola M Heller; Graham A W Rook; Terez Shea-Donohue; Sergei P Atamas
Journal:  J Leukoc Biol       Date:  2012-07-10       Impact factor: 4.962

Review 3.  Alternative splicing in multiple sclerosis and other autoimmune diseases.

Authors:  Irina Evsyukova; Jason A Somarelli; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

4.  Autoantibodies to a collagen-specific molecular chaperone, heat-shock protein 47, in systemic sclerosis.

Authors:  M Fujimoto; Y Hamaguchi; N Yazawa; K Komura; K Takehara; S Sato
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

5.  Characterisation of the immune response to type I collagen in scleroderma.

Authors:  Kenneth J Warrington; Usha Nair; Laura D Carbone; Andrew H Kang; Arnold E Postlethwaite
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 6.  Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 - An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives.

Authors:  Alin Laurentiu Tatu; Anca Arbune; Valentin Chioncel; Elena Niculet; Thomas Nadasdy; Carmen Bobeica; Alina Viorica Iancu; Caterina Dumitru; Valentin Tudor Popa; Nicolas Kluger; Victor Gabriel Clatici; Claudiu Ionut Vasile; Cristian Onisor; Alexandru Nechifor
Journal:  J Inflamm Res       Date:  2022-09-08

7.  Impact of Human Cytomegalovirus and Human Herpesvirus 6 Infection on the Expression of Factors Associated with Cell Fibrosis and Apoptosis: Clues for Implication in Systemic Sclerosis Development.

Authors:  Maria-Cristina Arcangeletti; Maria D'Accolti; Clara Maccari; Irene Soffritti; Flora De Conto; Carlo Chezzi; Adriana Calderaro; Clodoveo Ferri; Elisabetta Caselli
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

Review 8.  Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development.

Authors:  Andrea De Pieri; Benjamin D Korman; Astrid Jüngel; Karin Wuertz-Kozak
Journal:  Adv Biol (Weinh)       Date:  2021-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.